Amdocs price target raised to $115 from $105 at Barclays

Barclays raised the firm’s price target on Amdocs to $115 from $105 and keeps an Overweight rating on the shares. The company’s results and fiscal 2024 guidance were in line and it is well positioned to capitalize on the industry transition to new domains, the analyst tells investors in a research note.